C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2002
11/07/2002	US20020165202 Antiinflammatory agents; antiproliferative agents
11/07/2002	US20020165094 Herbicidal synergistic composition, and method of controlling weeds
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002	US20020164549 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/06/2002	EP1254885A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
11/06/2002	EP1254121A1 Preparation of sulfonamides
11/06/2002	EP1254120A1 Use of pyrimidine endothelin antagonists in companion animals
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1253926A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002	EP1031570B1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
11/06/2002	EP1030843A4 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
11/06/2002	EP1000038B1 Novel pyrimidin derivatives
11/06/2002	EP0927168B1 1,3-diheterocyclic metalloprotease inhibitors
11/06/2002	EP0912559B1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378537A 嘧啶衍生物 Pyrimidine derivatives
11/05/2002	US6476224 N-(4-cyano-2,5- difluoro-phenyl) -3-(dimethylaminocarbonylamino)-4,4,4-trifluoro-2-butenamide and 1,2-dimethoxyethane are heated to form ar(alk)yl uracil compound
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476040 Processes and intermediates for preparing anti-cancer compounds
11/05/2002	US6476031 Quinazoline derivatives as medicaments
11/05/2002	US6476026 Compounds and compositions as protease inhibitors
10/2002
10/31/2002	WO2002086078A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
10/31/2002	WO2002085866A1 Novel compounds
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085413A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
10/31/2002	WO2002026720A3 PIPERAZINE BASED INHIBITORS OF FACTOR Xa
10/31/2002	WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161234 Forming a diastereoselective epoxide from a chiral alpha-amino aldehyde
10/31/2002	US20020161226 Quinazolines for treating brain tumor
10/31/2002	US20020161225 Phenylurethane compounds and methods for producing same, asymmetric urea compounds and methods for producing same, barbituric acid derivative, and diazo thermal recording material containing the derivative
10/31/2002	US20020161224 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
10/31/2002	US20020161011 Potassium channel inhibitors
10/31/2002	US20020161010 Treatment of various disorders associated with enhanced activity of kinase p38-alpha and/or transforming growth factor beta; antiinflammatory agents
10/31/2002	US20020161009 Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
10/31/2002	US20020159973 Administering to the patient at least one statin (HMG-Coa-reductase inhibitor) in an amount effective to modulate MHC class II (Major Histocompability complex) or CD/40(antigen) expression in the patient
10/31/2002	US20020158227 Electrooptical liquid crystal system
10/31/2002	CA2444381A1 Novel compounds
10/30/2002	EP1252157A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
10/30/2002	EP1251839A2 Use of cox-2 inhibitors for the treatment of constipation
10/30/2002	EP1251831A1 Pharmaceutical compositions comprising a hmg coa reductase inhibitor
10/30/2002	EP1105359B1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
10/30/2002	EP0906289B1 Method of preparing 4,5,6-trichloro- and 2,4,5,6-tetrachloropyrimidine
10/30/2002	EP0799221B1 Quinazolines as inhibitors of endothelin converting enzyme
10/30/2002	CN1377357A Pyrazolo [4,3-d] pyrimidines
10/30/2002	CN1377356A Certain alkylene diamine-substituted heterocycles
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/29/2002	US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002	US6472529 Viricides
10/29/2002	US6472426 Anti- neoplastic, anti-diarrheal, anti-peristaltic, gastro-intestinal anti-spasmodic, anti-viral, anti-retroviral, anti-psoriasis and insecticidal compositions
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472399 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/29/2002	US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002	US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002	CA2158763C Novel process for preparation of clonidine derivatives
10/24/2002	WO2002083662A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
10/24/2002	WO2002083651A2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002	WO2002083650A1 Novel sulfonylamino-pyrimidines
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
10/24/2002	WO2002083143A1 Cxcr3 antagonists
10/24/2002	WO2002083142A1 Novel use of arylethenesulfonamide derivative
10/24/2002	WO2002002714A3 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/24/2002	US20020156313 Process for preparation of 2-phenyl acetic acid derivatives
10/24/2002	US20020156122 Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
10/24/2002	US20020156087 Pyrimidine or pyridine derivatives
10/24/2002	US20020156075 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	CA2444148A1 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
10/24/2002	CA2443910A1 Novel use of arylethenesulfonamide derivatives
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/23/2002	EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002	EP1250324A1 Biaryl compounds, their preparation and their use in therapy
10/23/2002	EP1250137A2 Jak/stat pathway inhibitors and the uses thereof
10/23/2002	EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002	EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002	EP0923561B1 Heterocyclic metalloprotease inhibitors
10/23/2002	EP0869947B1 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/23/2002	EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002	CN1376153A Amide compounds
10/23/2002	CN1376148A Rate-controlled particles
10/23/2002	CN1376145A A meta-nitro phenol derivative and a process for producing it
10/23/2002	CN1376143A Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
10/23/2002	CN1376057A Anti-virus composition
10/22/2002	US6469168 For the treatment of central nervous system disorders, especially anxiety
10/22/2002	US6469065 Compound that donates, transfers or releases nitric oxide, elevates endogenous levels of nitric oxide
10/22/2002	US6469013 Therapeutic compounds
10/22/2002	US6469005 Propargylether derivatives
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/17/2002	WO2002081467A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
10/17/2002	WO2002081456A1 Cyanamide, alkoxyamino, and urea derivatives of 4, 4-disubstituted-3, 4-dihydro-2 (1h)- quinazolinones as hiv reverse transcriptase inhibitors
10/17/2002	WO2002081454A1 Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
10/17/2002	WO2002067053A3 High speed photothermographic materials containing tellurium compounds and methods of using same

1 ... 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 ... 427